# Smoldering Inflammation in MS

> **NCT06591429** · — · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 25 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **RADIATION:** Radiotracer [11C]-CS1P1
- **RADIATION:** Radiotracer [11C]-DPA-713
- **DRUG:** anti-CD20 MS treatment
- **RADIATION:** Radiotracer [12F]-FDG

## Key facts

- **NCT ID:** NCT06591429
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-19
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591429, "Smoldering Inflammation in MS". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06591429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*